QurAlis Funding: $144M Raised, Series B (2024)

QurAlis funding overview

QurAlis is based in Cambridge, MA. QurAlis has raised $144M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2024. The round record for QurAlis runs through 2024; nothing later has been disclosed. Investors on record include EQT Life Sciences, Sanofi Ventures, Droia Ventures, ALS Investment Fund, Lilly, LS Polaris Innovation Fund and 9 others. 15 distinct backers are named across the disclosed rounds.

QurAlis at a glance

Total raised: $144M
Latest round: Series B
Latest round date: November 2024
Headquarters: Cambridge, MA
Notable investors: EQT Life Sciences, Sanofi Ventures, Droia Ventures, ALS Investment Fund, Lilly, LS Polaris Innovation Fund, Mission BioCapital, INKEF Capital

Frequently asked about QurAlis funding

How much has QurAlis raised?: QurAlis has raised $144M in total disclosed funding across the rounds on record.
Who has invested in QurAlis?: EQT Life Sciences, Sanofi Ventures, Droia Ventures, ALS Investment Fund, Lilly, LS Polaris Innovation Fund are named among the investors backing QurAlis.
What was the latest QurAlis funding round?: The most recent disclosed round is a Series B, announced in November 2024.
Where is QurAlis based?: QurAlis is based in Cambridge, MA.
When did QurAlis last raise?: The last disclosed QurAlis round closed in November 2024 at Series B.

Round data for QurAlis is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

QurAlis Funding: $144M Raised, Series B (2024)

QurAlis funding overview

QurAlis at a glance

Frequently asked about QurAlis funding

Companies related to QurAlis (36)

Browse related funding lists (8)